As of 3:59pm ET
| +0.95 / +5.96%|
The 7 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 21.00, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +24.26% increase from the last price of 16.90.
The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.